Inside Shs147.7b Dei Industries loan dispute
The Court of Appeal has halted proceedings in a Shs147.7 billion loan dispute involving pharmaceutical companies Dei Industries International Ltd and Dei Biopharma Ltd and their director, Dr Mathias Magoola, pending determination of an intended appeal challenging an audit report on their alleged indebtedness. Justice Florence Nakachwa, sitting as a
President Museveni, Dr. Magoola, Speaker Among Named Uganda Health Sector Transformation Champions
The NRM Government led by President Museveni has made significant achievements in the health sector, including improvements in infrastructure, human resources, disease prevention, and maternal and child health. The recognition of these champions highlights the government’s commitment to improving healthcare outcomes in Uganda. The champions include notable individuals such as
US FDA Accepts Uganda’s Dei BioPharma’s Application for Diabetes and Weight Loss Drug
The U.S. Food and Drug Administration (FDA) has accepted an Abbreviated New Drug Application (ANDA) from Uganda’s Dei BioPharma for liraglutide, a multibillion-dollar treatment for diabetes and weight loss, marketed under the brand name Victoza. The FDA’s decision, officially recorded on April 23, 2025, clears a path for Dei BioPharma
